127 related articles for article (PubMed ID: 16540633)
1. The phosphoinositide 3-kinase/Akt1/Par-4 axis: a cancer-selective therapeutic target.
Goswami A; Ranganathan P; Rangnekar VM
Cancer Res; 2006 Mar; 66(6):2889-92. PubMed ID: 16540633
[TBL] [Abstract][Full Text] [Related]
2. Akt signaling and cancer: surviving but not moving on.
Toker A; Yoeli-Lerner M
Cancer Res; 2006 Apr; 66(8):3963-6. PubMed ID: 16618711
[TBL] [Abstract][Full Text] [Related]
3. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
[TBL] [Abstract][Full Text] [Related]
4. Emodin negatively affects the phosphoinositide 3-kinase/AKT signalling pathway: a study on its mechanism of action.
Olsen BB; Bjørling-Poulsen M; Guerra B
Int J Biochem Cell Biol; 2007; 39(1):227-37. PubMed ID: 17018259
[TBL] [Abstract][Full Text] [Related]
5. PTEN, more than the AKT pathway.
Blanco-Aparicio C; Renner O; Leal JF; Carnero A
Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
[TBL] [Abstract][Full Text] [Related]
6. Activation of p53/p21/PUMA alliance and disruption of PI-3/Akt in multimodal targeting of apoptotic signaling cascades in cervical cancer cells by a pentacyclic triterpenediol from Boswellia serrata.
Bhushan S; Malik F; Kumar A; Isher HK; Kaur IP; Taneja SC; Singh J
Mol Carcinog; 2009 Dec; 48(12):1093-108. PubMed ID: 19544329
[TBL] [Abstract][Full Text] [Related]
7. Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer.
Kim D; Cheng GZ; Lindsley CW; Yang H; Cheng JQ
Curr Opin Investig Drugs; 2005 Dec; 6(12):1250-8. PubMed ID: 16370391
[TBL] [Abstract][Full Text] [Related]
8. Handicapping the race to develop inhibitors of the phosphoinositide 3-kinase/Akt/mammalian target of rapamycin pathway.
Granville CA; Memmott RM; Gills JJ; Dennis PA
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):679-89. PubMed ID: 16467077
[TBL] [Abstract][Full Text] [Related]
9. Targeting the PI3K-Akt pathway in kidney cancer.
Park JY; Lin PY; Weiss RH
Expert Rev Anticancer Ther; 2007 Jun; 7(6):863-70. PubMed ID: 17555396
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
Wang J; Yang L; Yang J; Kuropatwinski K; Wang W; Liu XQ; Hauser J; Brattain MG
Cancer Res; 2008 May; 68(9):3152-60. PubMed ID: 18451140
[TBL] [Abstract][Full Text] [Related]
11. Targeting Akt in cancer therapy.
LoPiccolo J; Granville CA; Gills JJ; Dennis PA
Anticancer Drugs; 2007 Sep; 18(8):861-74. PubMed ID: 17667591
[TBL] [Abstract][Full Text] [Related]
12. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone-related protein induces cell survival in human renal cell carcinoma through the PI3K Akt pathway: evidence for a critical role for integrin-linked kinase and nuclear factor kappa B.
Agouni A; Sourbier C; Danilin S; Rothhut S; Lindner V; Jacqmin D; Helwig JJ; Lang H; Massfelder T
Carcinogenesis; 2007 Sep; 28(9):1893-901. PubMed ID: 17468516
[TBL] [Abstract][Full Text] [Related]
14. Practicalities of drugging the phosphatidylinositol-3-kinase/Akt cell survival signaling pathway.
Powis G; Ihle N; Kirkpatrick DL
Clin Cancer Res; 2006 May; 12(10):2964-6. PubMed ID: 16707590
[No Abstract] [Full Text] [Related]
15. [Correlation of PI3K-Akt signal pathway to apoptosis of tumor cells].
Huang XL; Cui GH; Zhou KY
Ai Zheng; 2008 Mar; 27(3):331-6. PubMed ID: 18334129
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis and inactivation of the PI3-kinase pathway by tetrocarcin A in breast cancers.
Nakajima H; Sakaguchi K; Fujiwara I; Mizuta M; Tsuruga M; Magae J; Mizuta N
Biochem Biophys Res Commun; 2007 Apr; 356(1):260-5. PubMed ID: 17350598
[TBL] [Abstract][Full Text] [Related]
17. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells.
Lee DH; Szczepanski MJ; Lee YJ
J Cell Biochem; 2009 Apr; 106(6):1113-22. PubMed ID: 19229860
[TBL] [Abstract][Full Text] [Related]
18. Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo.
Tokuda E; Fujita N; Oh-hara T; Sato S; Kurata A; Katayama R; Itoh T; Takenawa T; Miyazono K; Tsuruo T
Cancer Res; 2007 Oct; 67(20):9666-76. PubMed ID: 17942896
[TBL] [Abstract][Full Text] [Related]
19. Activation of Akt predicts poor outcome in neuroblastoma.
Opel D; Poremba C; Simon T; Debatin KM; Fulda S
Cancer Res; 2007 Jan; 67(2):735-45. PubMed ID: 17234785
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
